At a glance

We are one of the world’s largest vaccines company, delivering vaccines that help protect people at all stages of life. Our R&D focuses on developing vaccines against infectious diseases that combine high medical need and strong market potential.

Belgium is the heart of GSK Vaccines, with three major vaccine sites, in Wavre, Rixensart and Gembloux, including the global headquarters from the vaccines division of the group. That also means we represent the largest industrial network of vaccines worldwide.

Almost one-fourth of the +9,000 people who work at GSK Vaccines in Belgium specialise in the discovery of new vaccines and the development of combination products for the prevention of infections that cause serious medical problems in the world.

Our pharmaceutical research and development activity covers a wide range of innovative medicines in the fields of respiratory diseases, HIV, infectious and immuno-inflammatory diseases and oncology. We are strengthening our research and development pipeline by focusing on immunology, human genetics and new technologies to provide patients with innovative treatments that meet their needs.